Serum YKL-40 Independently Predicts Outcome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma

BACKGROUND: Transcatheter arterial chemoembolization (TACE) is the most widely used treatment option for unresectable hepatocellular carcinoma (HCC). Elevated serum YKL-40 level has been shown to predict poor prognosis in HCC patients undergoing resection. This study was designed to validate the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Cheng-Bao, Wang, Can, Chen, Li-Li, Ma, Guo-Liang, Zhang, Shi-Cai, Su, Liang, Tian, Jian-Jun, Gai, Zhong-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435289/
https://www.ncbi.nlm.nih.gov/pubmed/22970277
http://dx.doi.org/10.1371/journal.pone.0044648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435289/
https://www.ncbi.nlm.nih.gov/pubmed/22970277
http://dx.doi.org/10.1371/journal.pone.0044648

Ejemplares similares